Whitebox Advisors’s Verona Pharma VRNA Stock Holding History

Whitebox Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,566,501	Closed	-$167M	–	525
2025 Q3	$167M	Buy	+1,566,501	New	+$164M	2.51%	7

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Whitebox Advisors's VRNA Position: Q4 2025 in Review

Whitebox Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,566,501 shares — an estimated $167M sold.

Whitebox Advisors first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $167M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Whitebox Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Whitebox Advisors sold 1,566,501 Verona Pharma shares in Q4 2025, an estimated $167M.
Whitebox Advisors first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Whitebox Advisors's Verona Pharma position peaked at $167M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Whitebox Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.